<unk>  is a kinase inhibitors that is FDA approved for the treatment of . There is a Black Box Warning for this drug as shown here.  Common adverse reactions include The most common adverse reactions for patients indicated for<unk>  come in the form of laboratory abnormalities. They include increase in glucose, creatinine, GGT, ALT, or lipase, decrease in lymphocyte count, hemoglobin, appetite, weight, calcium, or glucose, the presence of  diarrhea, rash, nausea, fatigue or alopecia.
Alpelisib
Duvelisib
Idelalisib
Vismodegib
Belinostat
Lenograstim
Glasdegib
Ivosidenib